GO
Loading...

Health Care

More

  • Martha Stewart ordeal changed me: Sam Waksal Tuesday, 13 Jan 2015 | 11:24 AM ET
    Sam Waksal of Kadmon Pharmaceuticals

    "Any event in life changes one. That was an event that probably changed me in many ways. I think I am a better person," biotech company founder Sam Waksal.

  • Orexigen CEO: Excited about obesity drug progress  Tuesday, 13 Jan 2015 | 2:22 PM ET

    Mike Narachi, Orexigen CEO, speaks with CNBC's Meg Tirrell about its obesity drug and program.

  • Juno's promising CAR-T immunotherapy  Tuesday, 13 Jan 2015 | 5:15 PM ET

    Hans Bishop, Juno Therapeutics co-founder and CEO, discusses promising data for new cancer immunotherapy approaches.

  • Health insurance paperwork wastes $375 billion Tuesday, 13 Jan 2015 | 11:54 AM ET

    A study says trillions of dollars could be saved in health-care billing and insurance administrative costs over the course of years.

  • Cigna's expansion strategy  Tuesday, 13 Jan 2015 | 10:17 AM ET

    David Cordani, Cigna president & CEO, weighs in on rival Aetna's wage plan and explains Cigna's growth strategy.

  • Chimerix tackles Ebola outbreak  Tuesday, 13 Jan 2015 | 11:46 AM ET

    Michelle Berrey, Chimerix CEO, discusses the testing of its Ebola drug Brincidofovir in a clinical setting in West Africa, with CNBC's Meg Tirrell.

  • Valeant CEO: Allegations about our business not true  Tuesday, 13 Jan 2015 | 12:46 PM ET

    Valeant CEO Mike Pearson tells CNBC's Meg Tirrell the company is on a mission to prove allegations against the business model are not true. Pearson says Valeant is unlikely to work with Bill Ackman.

  • The U.K.’s National Health Service, for decades a global case-study in universal healthcare, seems to be facing its biggest ever crisis of confidence.

  • Sass bets on airline, hedge fund stock Monday, 12 Jan 2015 | 12:00 AM ET
    A ground crewmember prepares to push back an American Airlines Boeing 737-823 jet at a terminal at  Miami International Airport.

    Martin D. Sass' stock picks are trades in three popular sectors: airlines, pharmaceuticals and asset management.

  • I am a better person: Sam Waksal  Tuesday, 13 Jan 2015 | 8:36 AM ET

    Sam Waksal, former Imclone Systems CEO, reveals how the ImClone scandal has impacted his life.

  • J&J CEO: Too early to fully assess Obamacare  Monday, 12 Jan 2015 | 5:43 PM ET

    Alex Gorsky, Johnson & Johnson chairman and CEO, discusses how the ACA and the recovery in the economy is impacting business.

  • Shire CEO: $5.2 billion NPS deal will pay off  Monday, 12 Jan 2015 | 5:16 PM ET

    Flemming Ornskov, Shire CEO, tells CNBC's Meg TIrrell it is the right time for the proposed acquisition of NPS Pharmaceuticals.

  • Merck CEO: Deals create value  Monday, 12 Jan 2015 | 4:27 PM ET

    Merck CEO Ken Frazier plans to focus on its specialized area strategy in 2015, with CNCB's Meg Tirrell.

  • Biogen Idec beefs up pain pipeline  Monday, 12 Jan 2015 | 3:16 PM ET

    Dr. George Scangos, Biogen Idec CEO, discusses new therapies in multiple sclerosis, Alzheimer's disease and pain.

  • Targeting cancer's metabolism  Monday, 12 Jan 2015 | 2:46 PM ET

    Dr. David Schenkein, Agios CEO, explains a cancer's metabolism, and the company's priorities for 2015.

  • Bluebird's catalysts in 2015  Monday, 12 Jan 2015 | 1:44 PM ET

    Bluebird Bio CEO Nick Leschly, provides insight to how gene therapy can work to treat blood disorders, and sickle cell anemia.

  • Actavis CEO: Good can come from activists  Monday, 12 Jan 2015 | 12:38 PM ET

    Brent Saunders, Actavis CEO, discusses the deal environment, the process of acquiring Allergan and the good that comes from activist investors.

  • Celgene CEO: Creating a great future  Monday, 12 Jan 2015 | 11:45 AM ET

    CNBC's Meg Tirrell speaks to Robert Hugin, Celgene chairman & CEO, about the company's ambitious long-term guidance and broad-based drug pipeline.

  • Analyzing Eli Lilly's drug pipeline  Monday, 12 Jan 2015 | 10:15 AM ET

    CNBC's Meg Tirrell speaks to John Lechleiter, Eli Lilly CEO, about the strength and outlook for the health care sector, and what new drugs he's most excited about.

  • The great Obamacare-Medicaid bait 'n' switch Monday, 12 Jan 2015 | 2:21 PM ET

    More and more Americans are "covered," but fewer and fewer Americans will actually be able to get health care, says Jake Novak. Here's why.

Contact Health Care

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

 

  • Dan Mangan is a reporter covering health care for CNBC.com.

  • Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.

  • Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.